BACKGROUND: Although neuromelanin-sensitive magnetic resonance imaging (NM-MRI) has been used to evaluate early neurodegeneration in Parkinson's disease, studies concentrating on the locus coeruleus (LC) in pre-dementia stages of dementia with Lewy bodies (DLB) are lacking. OBJECTIVES: The aims were to evaluate NM-MRI signal changes in the LC in patients with mild cognitive impairment with Lewy bodies (MCI-LB) compared to healthy controls (HC) and to identify the cognitive correlates of the changes. We also aimed to test the hypothesis of a caudal-rostral α-synuclein pathology spread using NM-MRI of the different LC subparts. METHODS: A total of 38 MCI-LB patients and 59 HCs underwent clinical and cognitive testing and NM-MRI of the LC. We calculated the contrast ratio of NM-MRI signal (LC-CR) in the whole LC as well as in its caudal, middle, and rostral MRI slices, and we compared the LC-CR values between the MCI-LB and HC groups. Linear regression analyses were performed to assess the relationship between the LC-CR and cognitive outcomes. RESULTS: The MCI-LB group exhibited a significant reduction in the right LC-CR compared to HCs (P = 0.021). The right LC-CR decrease was associated with impaired visuospatial memory in the MCI-LB group. Only the caudal part of the LC exhibited significant LC-CR decreases in MCI-LB patients compared to HCs on both sides (P < 0.0001). CONCLUSIONS: This is the first study that focuses on LC-CRs in MCI-LB patients and analyzes the LC subparts, offering new insights into the LC integrity alterations in the initial stages of DLB and their clinical correlates. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

1st Department of Neurology Faculty of Medicine and St Anne's University Hospital Masaryk University Brno Czech Republic

Applied Neuroscience Research Group Central European Institute of Technology CEITEC Masaryk University Brno Czech Republic

International Clinical Research Center ICRC Faculty of Medicine and St Anne's University Hospital Masaryk University Brno Czech Republic

Multimodal and Functional Neuroimaging Research Group Central European Institute of Technology CEITEC Masaryk University Brno Czech Republic

See more in PubMed

Höglinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W, et al. A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 2024;23(2):191–204. PubMed

Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, et al. A biological definition of neuronal α‐synuclein disease: towards an integrated staging system for research. Lancet Neurol 2024;23(2):178–190. PubMed

Müller‐Nedebock AC, Dekker MCJ, Farrer MJ, Hattori N, Lim SY, Mellick GD, et al. Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson's disease. NPJ Parkinsons Dis 2023;9(1):110. PubMed PMC

Sejnoha Minsterova A, Klobusiakova P, Pies A, Galaz Z, Mekyska J, Novakova L, et al. Patterns of diffusion kurtosis changes in Parkinson's disease subtypes. Parkinsonism Relat Disord 2020;81:96–102. PubMed

Theis H, Pavese N, Rektorová I, Van Eimeren T. Imaging biomarkers in prodromal and earliest phases of Parkinson's disease. J Parkinsons Dis 2024;3:1–13. PubMed PMC

Borghammer P, Van Den Berge N. Brain‐first versus gut‐first Parkinson's disease: a Hypothesis. Van Laar T, editor. J Parkinsons Dis 2019;9(s2):S281–S295. PubMed PMC

Bohnen NI, Postuma RB. Body‐first versus brain‐first biological subtyping of Parkinson's disease. Brain 2020;143(10):2871–2873. PubMed PMC

Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S, et al. Neuropathological evidence of body‐first vs. brain‐first Lewy body disease. Neurobiol Dis 2021;161:105557. PubMed

Horsager J, Borghammer P. Brain‐first vs. body‐first Parkinson's disease: an update on recent evidence. Parkinsonism Relat Disord 2024;122:106101. PubMed

McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 2020;94(17):743–755. PubMed PMC

Donaghy PC, Carrarini C, Ferreira D, Habich A, Aarsland D, Babiloni C, et al. Research diagnostic criteria for mild cognitive impairment with Lewy bodies: a systematic review and meta‐analysis. Alzheimers Dement 2023;19(7):3186–3202. PubMed PMC

Donaghy PC, Ciafone J, Durcan R, Hamilton CA, Barker S, Lloyd J, et al. Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile. Psychol Med 2022;52(6):1147–1155. PubMed

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 2017;89(1):88–100. PubMed PMC

Hansen D, Ling H, Lashley T, Holton JL, Warner TT. Review: clinical, neuropathological and genetic features of Lewy body dementias. Neuropathol Appl Neurobiol 2019;45(7):635–654. PubMed

Benarroch E. What are current concepts on the functional Organization of the Locus Coeruleus and its Role in cognition and neurodegeneration? Neurology 2023;100(3):132–137. PubMed

Li Y, Wang C, Wang J, Zhou Y, Ye F, Zhang Y, et al. Mild cognitive impairment in de novo Parkinson's disease: a neuromelanin MRI study in locus coeruleus. Mov Disord 2019;34(6):884–892. PubMed

Sulzer D, Cassidy C, Horga G, Kang UJ, Fahn S, Casella L, et al. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease. NPJ Parkinsons Dis 2018;4(1):11. PubMed PMC

Zecca L, Tampellini D, Gerlach M, Riederer P, Fariello RG, Sulzer D. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Mol Pathol 2001;54(6):414–418. PubMed PMC

Gaurav R, Yahia‐Cherif L, Pyatigorskaya N, Mangone G, Biondetti E, Valabrègue R, et al. Longitudinal changes in neuromelanin MRI signal in Parkinson's disease: a progression marker. Mov Disord 2021;36(7):1592–1602. PubMed PMC

Wang L, Yan Y, Zhang L, Liu Y, Luo R, Chang Y. Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease. J Neural Transm 2021;128(2):171–179. PubMed PMC

Ehrminger M, Latimier A, Pyatigorskaya N, Garcia‐Lorenzo D, Leu‐Semenescu S, Vidailhet M, et al. The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain 2016;139(4):1180–1188. PubMed

Gaurav R, Pyatigorskaya N, Biondetti E, Valabrègue R, Yahia‐Cherif L, Mangone G, et al. Deep learning‐based neuromelanin mri changes of isolated rem sleep behavior disorder. Mov Disord 2022;37(5):1064–1069. PubMed PMC

Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta‐Cabronero J, Callaghan MF, et al. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain 2019;142(9):2558–2571. PubMed PMC

Pavese N, Tai YF. Nigrosome imaging and neuromelanin sensitive MRI in diagnostic evaluation of parkinsonism. Mov Disord Clin Pract 2018;5(2):131–140. PubMed PMC

Doppler CEJ, Kinnerup MB, Brune C, Farrher E, Betts M, Fedorova TD, et al. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease. Brain 2021;144(9):2732–2744. PubMed

Madelung CF, Meder D, Fuglsang SA, Marques MM, Boer VO, Madsen KH, et al. Locus coeruleus shows a spatial pattern of structural disintegration in Parkinson's disease. Mov Disord 2022;37(3):479–489. PubMed PMC

Bari B, Chokshi V, Schmidt K. Locus coeruleus‐norepinephrine: basic functions and insights into Parkinson's disease. Neural Regen Res 2020;15(6):1006. PubMed PMC

Borghammer P. The brain‐first vs. body‐first model of Parkinson's disease with comparison to alternative models. J Neural Transm 2023;130(6):737–753. PubMed

Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez‐Porcel F, Pilotto A, et al. Dementia with Lewy bodies: impact of co‐pathologies and implications for clinical trial design. Alzheimers Dement 2023;19(1):318–332. PubMed PMC

Beardmore R, Hou R, Darekar A, Holmes C, Boche D. The locus coeruleus in aging and Alzheimer's disease: a postmortem and brain imaging review. J Alzheimers Dis 2021;83(1):5–22. PubMed PMC

Gonzalez MC, Ashton NJ, Gomes BF, Tovar‐Rios DA, Blanc F, Karikari TK, et al. Association of Plasma p‐tau181 and p‐tau231 concentrations with cognitive decline in patients with probable dementia with Lewy bodies. JAMA Neurol 2022;79(1):32. PubMed PMC

Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol 2020;19(5):422–433. PubMed

Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, et al. Blood‐based biomarkers for Alzheimer's disease: towards clinical implementation. Lancet Neurol 2022;21(1):66–77. PubMed

Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement disorder society task force guidelines. Mov Disord 2012;27(3):349–356. PubMed PMC

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53(4):695–699. PubMed

Clewett DV, Lee TH, Greening S, Ponzio A, Margalit E, Mather M. Neuromelanin marks the spot: identifying a locus coeruleus biomarker of cognitive reserve in healthy aging. Neurobiol Aging 2016;37:117–126. PubMed PMC

Elman JA, Puckett OK, Beck A, Fennema‐Notestine C, Cross LK, Dale AM, et al. MRI‐assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction. Alzheimers Dement 2021;17(6):1017–1025. PubMed PMC

Mather M, Joo Yoo H, Clewett DV, Lee TH, Greening SG, Ponzio A, et al. Higher locus coeruleus MRI contrast is associated with lower parasympathetic influence over heart rate variability. Neuroimage 2017;150:329–335. PubMed PMC

Ye R, Rua C, O'Callaghan C, Jones PS, Hezemans FH, Kaalund SS, et al. An in vivo probabilistic atlas of the human locus coeruleus at ultra‐high field. Neuroimage 2021;225:117487. PubMed PMC

Keren NI, Taheri S, Vazey EM, Morgan PS, Granholm ACE, Aston‐Jones GS, et al. Histologic validation of locus coeruleus MRI contrast in post‐mortem tissue. Neuroimage 2015;113:235–245. PubMed PMC

O'Callaghan C, Hezemans FH, Ye R, Rua C, Jones PS, Murley AG, et al. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease. Brain 2021;144(8):2513–2526. PubMed PMC

Ye R, O'Callaghan C, Rua C, Hezemans FH, Holland N, Malpetti M, et al. Locus coeruleus integrity from 7 t mri relates to apathy and cognition in parkinsonian disorders. Mov Disord 2022;37(8):1663–1672. PubMed PMC

Nobileau A, Gaurav R, Chougar L, Faucher A, Valabrègue R, Mangone G, et al. Neuromelanin‐sensitive magnetic resonance imaging changes in the locus coeruleus/subcoeruleus complex in patients with typical and atypical parkinsonism. Mov Disord 2023;38(3):479–484. PubMed

Sun J, Ma J, Gao L, Wang J, Zhang D, Chen L, et al. Disruption of locus coeruleus‐related functional networks in Parkinson's disease. NPJ Parkinsons Dis 2023;9(1):81. PubMed PMC

Raunio A, Kaivola K, Tuimala J, Kero M, Oinas M, Polvikoski T, et al. Lewy‐related pathology exhibits two anatomically and genetically distinct progression patterns: a population‐based study of Finns aged 85+. Acta Neuropathol (Berl) 2019;138(5):771–782. PubMed PMC

Betts MJ, Cardenas‐Blanco A, Kanowski M, Spottke A, Teipel SJ, Kilimann I, et al. Locus coeruleus MRI contrast is reduced in Alzheimer's disease dementia and correlates with CSF Aβ levels. Alzheimers Dement (Amst) 2019;11:281–285. PubMed PMC

Benedict RH. Brief visuospatial memory test‐‐revised. Lutz, Florida: Psychological Assessment Resources, Inc; 1997.

Kemp J, Philippi N, Phillipps C, Demuynck C, Albasser T, Martin‐Hunyadi C, et al. Cognitive profile in prodromal dementia with Lewy bodies. Alzheimers Res Ther 2017;9(1):19. PubMed PMC

Mondon K, Gochard A, Marque A, Armand A, Beauchamp D, Prunier C, et al. Visual recognition memory differentiates dementia with Lewy bodies and Parkinson's disease dementia. J Neurol Neurosurg Psychiatry 2006;78(7):738–741. PubMed PMC

McLaughlin NCR, Chang AC, Malloy P. Verbal and nonverbal learning and recall in dementia with Lewy bodies and Alzheimer's disease. Appl Neuropsychol Adult 2012;19(2):86–89. PubMed

Schwertner E, Pereira JB, Xu H, Secnik J, Winblad B, Eriksdotter M, et al. Behavioral and psychological symptoms of dementia in different dementia disorders: a large‐scale study of 10,000 individuals. J Alzheimers Dis 2022;87(3):1307–1318. PubMed PMC

Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord 2004;19(1):60–67. PubMed

Kempadoo KA, Mosharov EV, Choi SJ, Sulzer D, Kandel ER. Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory. Proc Natl Acad Sci 2016;113(51):14835–14840. PubMed PMC

Uematsu A, Tan BZ, Johansen JP. Projection specificity in heterogeneous locus coeruleus cell populations: implications for learning and memory. Learn Mem 2015;22(9):444–451. PubMed PMC

Breton‐Provencher V, Drummond GT, Sur M. Locus coeruleus norepinephrine in learned behavior: anatomical modularity and spatiotemporal integration in targets. Front Neural Circuits 2021;15:638007. PubMed PMC

Salimi S, Irish M, Foxe D, Hodges JR, Piguet O, Burrell JR. Can visuospatial measures improve the diagnosis of Alzheimer's disease? Alzheimers Dement (Amst) 2018;10(1):66–74. PubMed PMC

Guinea‐Izquierdo A, Giménez M, Martínez‐Zalacaín I, Del Cerro I, Canal‐Noguer P, Blasco G, et al. Lower locus coeruleus MRI intensity in patients with late‐life major depression. PeerJ 2021;9:e10828. PubMed PMC

Shibata E, Sasaki M, Tohyama K, Otsuka K, Sakai A. Reduced signal of locus ceruleus in depression in quantitative neuromelanin magnetic resonance imaging. Neuroreport 2007;18(5):415–418. PubMed

Hansen N. Locus coeruleus malfunction is linked to psychopathology in prodromal dementia with Lewy bodies. Front Aging Neurosci 2021;13:641101. PubMed PMC

Veréb D, Mijalkov M, Canal‐Garcia A, Chang YW, Gomez‐Ruiz E, Gerboles BZ, et al. Age‐related differences in the functional topography of the locus coeruleus and their implications for cognitive and affective functions. Elife 2023;12:RP87188. PubMed PMC

Laurencin C, Lancelot S, Brosse S, Mérida I, Redouté J, Greusard E, et al. Noradrenergic alterations in Parkinson's disease: a combined 11C‐yohimbine PET/neuromelanin MRI study. Brain 2024;147(4):1377–1388. PubMed PMC

Sommerauer M, Fedorova TD, Hansen AK, Knudsen K, Otto M, Jeppesen J, et al. Evaluation of the noradrenergic system in Parkinson's disease: an 11C‐MeNER PET and neuromelanin MRI study. Brain 2018;141(2):496–504. PubMed